7, 11 a.m. to 4 p.m. Join Downtown Concord for Art Walk on Union hosted in partnership with @concorddowntown and sponsored by Eli Lilly and Company ... Grounds are at4759 NC Highway 49 N.

Cabarrus and Charlotte leaders, students and Eli Lilly and Company representatives were on hand Friday, Sept. 6, to celebrate ...

Eli Lilly (NYSE: LLY) is one of the world's top pharmaceutical companies, selling treatments for a wide range of diseases -- from diabetes to cancer. But one type of product has stood out in ...

Positive late-stage trial results come after Novo Nordisk's weekly insulin was rejected by FDA A pair of late-stage trials found that Eli Lilly & Co.'s experimental once-weekly insulin can lower ...

A pair of late-stage trials found that Eli Lilly & Co.’s experimental once-weekly insulin can lower blood sugar as effectively as widely used daily insulins, the drugmaker said Thursday ...

An Eli Lilly insulin engineered for once-weekly dosing now has preliminary results from two more pivotal studies showing the injection was comparable to once-daily insulin, a new slate of data ...

The primary cause for the selloff could be because Eli Lilly (NYSE:LLY) has cut the knees out from under Hims & Hers biggest selling point: selling weight-loss drugs at a steep discount.

Eli Lilly (NYSE: LLY) stock is up a mammoth 770% in five years. It is trading at new all-time highs in 2024 thanks to the incredible success and popularity of its diabetes and weight loss products ...

Drugmaker Eli Lilly said Tuesday it will sell single-use vials of its weight-loss drug Zepbound at a fraction of the price of its pens, amid skyrocketing demand among Americans for anti-obesity ...

In a step towards making the drugs more affordable, Eli Lilly announced that its weight loss drug, Zepbound, will be available at a much lower cost for patients. Additionally, the company will ...

Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand ...

Eli Lilly said it has begun selling vials of the smallest, starter dose of its popular weight-loss drug Zepbound in the United States for $399 for a month on its direct-to-consumer website to ...